{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:55:45Z","timestamp":1786982145698,"version":"build-2736575974"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s11926-021-01050-6","type":"journal-article","created":{"date-parts":[[2021,12,31]],"date-time":"2021-12-31T05:02:26Z","timestamp":1640926946000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Hyperuricemia, Gout, and the Brain\u2014an Update"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1087-7768","authenticated-orcid":false,"given":"Augustin","family":"Latourte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Dumurgier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Paquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Richette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,30]]},"reference":[{"issue":"11","key":"1050_CR1","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/nrrheum.2014.124","volume":"10","author":"P Richette","year":"2014","unstructured":"Richette P, Perez-Ruiz F, Doherty M, Jansen TL, Nuki G, Pascual E, et al. Improving cardiovascular and renal outcomes in gout: what should we target? Nat Rev Rheumatol. 2014;10(11):654\u201361.","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"1050_CR2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jbspin.2015.01.002","volume":"82","author":"T Bardin","year":"2015","unstructured":"Bardin T. Hyperuricemia starts at 360 micromoles (6 mg\/dL). Joint Bone Spine. 2015;82(3):141\u20133.","journal-title":"Joint Bone Spine"},{"issue":"6","key":"1050_CR3","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1002\/art.41247","volume":"72","author":"JD FitzGerald","year":"2020","unstructured":"FitzGerald JD, Dalbeth N, Mikuls T, Brignardello-Petersen R, Guyatt G, Abeles AM, et al. 2020 American College of Rheumatology guideline for the management of gout. Arthritis Rheumatol. 2020;72(6):879\u201395.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"1050_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","volume":"76","author":"P Richette","year":"2017","unstructured":"Richette P, Doherty M, Pascual E, Barskova V, Becce F, Castaneda-Sanabria J, et al. 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis. 2017;76(1):29\u201342.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"1050_CR5","doi-asserted-by":"publisher","first-page":"3763","DOI":"10.1073\/pnas.1320393111","volume":"111","author":"JT Kratzer","year":"2014","unstructured":"Kratzer JT, Lanaspa MA, Murphy MN, Cicerchi C, Graves CL, Tipton PA, et al. Evolutionary history and metabolic insights of ancient mammalian uricases. Proc Natl Acad Sci U S A. 2014;111(10):3763\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"1050_CR6","doi-asserted-by":"publisher","first-page":"6858","DOI":"10.1073\/pnas.78.11.6858","volume":"78","author":"BN Ames","year":"1981","unstructured":"Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci U S A. 1981;78(11):6858\u201362.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1050_CR7","first-page":"640","volume":"19","author":"A De Giorgi","year":"2015","unstructured":"De Giorgi A, Fabbian F, Pala M, Tiseo R, Parisi C, Misurati E, et al. Uric acid: friend or foe? Uric acid and cognitive function \u201cGout kills more wise men than simple.\u201d Eur Rev Med Pharmacol Sci. 2015;19(4):640\u20136.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"Suppl 3","key":"1050_CR8","doi-asserted-by":"publisher","first-page":"S125","DOI":"10.3233\/JAD-132738","volume":"42","author":"E Radi","year":"2014","unstructured":"Radi E, Formichi P, Battisti C, Federico A. Apoptosis and oxidative stress in neurodegenerative diseases. J Alzheimers Dis. 2014;42(Suppl 3):S125\u201352.","journal-title":"J Alzheimers Dis"},{"key":"1050_CR9","doi-asserted-by":"crossref","unstructured":"Yu W, Cheng JD. Uric Acid and Cardiovascular disease: an update from molecular mechanism to clinical perspective. Front Pharmacol. 2020;11:582680.","DOI":"10.3389\/fphar.2020.582680"},{"issue":"6","key":"1050_CR10","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1172\/JCI42344","volume":"120","author":"A So","year":"2010","unstructured":"So A, Thorens B. Uric acid transport and disease. J Clin Invest. 2010;120(6):1791\u20139.","journal-title":"J Clin Invest"},{"issue":"32","key":"1050_CR11","doi-asserted-by":"publisher","first-page":"14351","DOI":"10.1073\/pnas.1001072107","volume":"107","author":"MS Hershfield","year":"2010","unstructured":"Hershfield MS, Roberts LJ 2nd, Ganson NJ, Kelly SJ, Santisteban I, Scarlett E, et al. Treating gout with pegloticase, a PEGylated urate oxidase, provides insight into the importance of uric acid as an antioxidant in vivo. Proc Natl Acad Sci U S A. 2010;107(32):14351\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"1050_CR12","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1253\/circj.CJ-18-0082","volume":"82","author":"M Furuhashi","year":"2018","unstructured":"Furuhashi M, Matsumoto M, Tanaka M, Moniwa N, Murase T, Nakamura T, et al. Plasma xanthine oxidoreductase activity as a novel biomarker of metabolic disorders in a general population. Circ J. 2018;82(7):1892\u20139.","journal-title":"Circ J"},{"issue":"1","key":"1050_CR13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1124\/pr.58.1.6","volume":"58","author":"P Pacher","year":"2006","unstructured":"Pacher P, Nivorozhkin A, Szabo C. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev. 2006;58(1):87\u2013114.","journal-title":"Pharmacol Rev"},{"issue":"1","key":"1050_CR14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-019-0115-y","volume":"5","author":"N Dalbeth","year":"2019","unstructured":"Dalbeth N, Choi HK, Joosten LAB, Khanna PP, Matsuo H, Perez-Ruiz F, et al. Gout Nat Rev Dis Primers. 2019;5(1):69.","journal-title":"Gout Nat Rev Dis Primers"},{"issue":"2","key":"1050_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41584-019-0334-3","volume":"16","author":"LAB Joosten","year":"2020","unstructured":"Joosten LAB, Crisan TO, Bjornstad P, Johnson RJ. Asymptomatic hyperuricaemia: a silent activator of the innate immune system. Nat Rev Rheumatol. 2020;16(2):75\u201386.","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"1050_CR16","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1136\/annrheumdis-2014-206564","volume":"75","author":"TO Crisan","year":"2016","unstructured":"Crisan TO, Cleophas MC, Oosting M, Lemmers H, Toenhake-Dijkstra H, Netea MG, et al. Soluble uric acid primes TLR-induced proinflammatory cytokine production by human primary cells via inhibition of IL-1Ra. Ann Rheum Dis. 2016;75(4):755\u201362.","journal-title":"Ann Rheum Dis"},{"issue":"21","key":"1050_CR17","doi-asserted-by":"publisher","first-page":"5485","DOI":"10.1073\/pnas.1620910114","volume":"114","author":"TO Crisan","year":"2017","unstructured":"Crisan TO, Cleophas MCP, Novakovic B, Erler K, van de Veerdonk FL, Stunnenberg HG, et al. Uric acid priming in human monocytes is driven by the AKT-PRAS40 autophagy pathway. Proc Natl Acad Sci U S A. 2017;114(21):5485\u201390.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1050_CR18","doi-asserted-by":"publisher","first-page":"39884","DOI":"10.1038\/srep39884","volume":"7","author":"TT Braga","year":"2017","unstructured":"Braga TT, Forni MF, Correa-Costa M, Ramos RN, Barbuto JA, Branco P, et al. Soluble uric acid activates the NLRP3 inflammasome. Sci Rep. 2017;7:39884.","journal-title":"Sci Rep"},{"key":"1050_CR19","doi-asserted-by":"crossref","unstructured":"Jin Y, Fu J. Novel insights into the NLRP 3 inflammasome in atherosclerosis. J Am Heart Assoc. 2019;8(12):e012219.","DOI":"10.1161\/JAHA.119.012219"},{"issue":"12","key":"1050_CR20","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377(12):1119\u201331.","journal-title":"N Engl J Med"},{"issue":"26","key":"1050_CR21","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","volume":"381","author":"JC Tardif","year":"2019","unstructured":"Tardif JC, Kouz S, Waters DD, Bertrand OF, Diaz R, Maggioni AP, et al. Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med. 2019;381(26):2497\u2013505.","journal-title":"N Engl J Med"},{"issue":"8","key":"1050_CR22","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/ni.1636","volume":"9","author":"A Halle","year":"2008","unstructured":"Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG, Reinheckel T, et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol. 2008;9(8):857\u201365.","journal-title":"Nat Immunol"},{"issue":"7784","key":"1050_CR23","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","volume":"575","author":"C Ising","year":"2019","unstructured":"Ising C, Venegas C, Zhang S, Scheiblich H, Schmidt SV, Vieira-Saecker A, et al. NLRP3 inflammasome activation drives tau pathology. Nature. 2019;575(7784):669\u201373.","journal-title":"Nature"},{"key":"1050_CR24","doi-asserted-by":"crossref","unstructured":"Trudler D, Nazor KL, Eisele YS, Grabauskas T, Dolatabadi N, Parker J, et al. Soluble alpha-synuclein-antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia. Proc Natl Acad Sci U S A. 2021;118(15).","DOI":"10.1073\/pnas.2025847118"},{"issue":"2","key":"1050_CR25","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41419-017-0153-x","volume":"9","author":"C Ising","year":"2018","unstructured":"Ising C, Heneka MT. Functional and structural damage of neurons by innate immune mechanisms during neurodegeneration. Cell Death Dis. 2018;9(2):120.","journal-title":"Cell Death Dis"},{"issue":"4","key":"1050_CR26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1159\/000346370","volume":"12","author":"NR McFarland","year":"2013","unstructured":"McFarland NR, Burdett T, Desjardins CA, Frosch MP, Schwarzschild MA. Postmortem brain levels of urate and precursors in Parkinson\u2019s disease and related disorders. Neurodegener Dis. 2013;12(4):189\u201398.","journal-title":"Neurodegener Dis"},{"issue":"12","key":"1050_CR27","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1001\/archneurol.2009.247","volume":"66","author":"A Ascherio","year":"2009","unstructured":"Ascherio A, LeWitt PA, Xu K, Eberly S, Watts A, Matson WR, et al. Urate as a predictor of the rate of clinical decline in Parkinson disease. Arch Neurol. 2009;66(12):1460\u20138.","journal-title":"Arch Neurol"},{"issue":"4","key":"1050_CR28","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.3233\/JAD-2010-1330","volume":"19","author":"GL Bowman","year":"2010","unstructured":"Bowman GL, Shannon J, Frei B, Kaye JA, Quinn JF. Uric acid as a CNS antioxidant. J Alzheimers Dis. 2010;19(4):1331\u20136.","journal-title":"J Alzheimers Dis"},{"key":"1050_CR29","doi-asserted-by":"crossref","unstructured":"Chen X, Guo X, Huang R, Chen Y, Zheng Z, Shang H. Serum uric acid levels in patients with Alzheimer\u2019s disease: a meta-analysis. PLoS One. 2014;9(4):e94084.","DOI":"10.1371\/journal.pone.0094084"},{"issue":"1","key":"1050_CR30","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11357-016-9871-8","volume":"38","author":"AA Khan","year":"2016","unstructured":"Khan AA, Quinn TJ, Hewitt J, Fan Y, Dawson J. Serum uric acid level and association with cognitive impairment and dementia: systematic review and meta-analysis. Age (Dordr). 2016;38(1):16.","journal-title":"Age (Dordr)"},{"issue":"Pt 2","key":"1050_CR31","first-page":"377","volume":"132","author":"SM Euser","year":"2009","unstructured":"Euser SM, Hofman A, Westendorp RG, Breteler MM. Serum uric acid and cognitive function and dementia. Brain. 2009;132(Pt 2):377\u201382.","journal-title":"Brain"},{"issue":"3","key":"1050_CR32","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1136\/annrheumdis-2016-210767","volume":"77","author":"A Latourte","year":"2018","unstructured":"Latourte A, Soumare A, Bardin T, Perez-Ruiz F, Debette S, Richette P. Uric acid and incident dementia over 12 years of follow-up: a population-based cohort study. Ann Rheum Dis. 2018;77(3):328\u201335.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1050_CR33","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.jalz.2019.01.014","volume":"15","author":"L Scheepers","year":"2019","unstructured":"Scheepers L, Jacobsson LTH, Kern S, Johansson L, Dehlin M, Skoog I. Urate and risk of Alzheimer\u2019s disease and vascular dementia: a population-based study. Alzheimers Dement. 2019;15(6):754\u201363.","journal-title":"Alzheimers Dement"},{"key":"1050_CR34","doi-asserted-by":"crossref","unstructured":"Cao Z, Xu C, Yang H, Li S, Xu F, Zhang Y, et al. Associations of BMI and serum urate with developing dementia: a prospective cohort study. J Clin Endocrinol Metab. 2020;105(12).","DOI":"10.1210\/clinem\/dgaa638"},{"issue":"5","key":"1050_CR35","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1111\/ene.12969","volume":"23","author":"BS Ye","year":"2016","unstructured":"Ye BS, Lee WW, Ham JH, Lee JJ, Lee PH, Sohn YH, et al. Does serum uric acid act as a modulator of cerebrospinal fluid Alzheimer\u2019s disease biomarker related cognitive decline? Eur J Neurol. 2016;23(5):948\u201357.","journal-title":"Eur J Neurol"},{"issue":"1","key":"1050_CR36","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3233\/JAD-201192","volume":"81","author":"LL Li","year":"2021","unstructured":"Li LL, Ma YH, Bi YL, Sun FR, Hu H, Hou XH, et al. Serum uric acid may aggravate Alzheimer\u2019s disease risk by affecting amyloidosis in cognitively intact older adults: the CABLE study. J Alzheimers Dis. 2021;81(1):389\u2013401.","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"1050_CR37","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1002\/jcp.25509","volume":"232","author":"G Desideri","year":"2017","unstructured":"Desideri G, Gentile R, Antonosante A, Benedetti E, Grassi D, Cristiano L, et al. Uric acid amplifies Abeta amyloid effects involved in the cognitive dysfunction\/dementia: evidences from an experimental model in vitro. J Cell Physiol. 2017;232(5):1069\u201378.","journal-title":"J Cell Physiol"},{"key":"1050_CR38","doi-asserted-by":"crossref","unstructured":"Efstathiadou A, Gill D, McGrane F, Quinn T, Dawson J. Genetically determined uric acid and the risk of cardiovascular and neurovascular diseases: a Mendelian randomization study of outcomes investigated in randomized trials. J Am Heart Assoc. 2019;8(17):e012738.","DOI":"10.1161\/JAHA.119.012738"},{"issue":"167","key":"1050_CR39","first-page":"e11","volume":"91","author":"Z Wang","year":"2020","unstructured":"Wang Z, Meng L, Shen L, Ji HF. Impact of modifiable risk factors on Alzheimer\u2019s disease: a two-sample Mendelian randomization study. Neurobiol Aging. 2020;91(167):e11\u20139.","journal-title":"Neurobiol Aging"},{"issue":"4","key":"1050_CR40","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.3233\/JAD-180538","volume":"65","author":"H Yuan","year":"2018","unstructured":"Yuan H, Yang W. Genetically Determined serum uric acid and Alzheimer\u2019s disease risk. J Alzheimers Dis. 2018;65(4):1259\u201365.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1050_CR41","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1017\/S0317167100012981","volume":"40","author":"C Shen","year":"2013","unstructured":"Shen C, Guo Y, Luo W, Lin C, Ding M. Serum urate and the risk of Parkinson\u2019s disease: results from a meta-analysis. Can J Neurol Sci. 2013;40(1):73\u20139.","journal-title":"Can J Neurol Sci"},{"key":"1050_CR42","doi-asserted-by":"crossref","unstructured":"Wen M, Zhou B, Chen YH, Ma ZL, Gou Y, Zhang CL, et al. Serum uric acid levels in patients with Parkinson\u2019s disease: a meta-analysis. PLoS One. 2017;12(3):e0173731.","DOI":"10.1371\/journal.pone.0173731"},{"issue":"1","key":"1050_CR43","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/ene.12533","volume":"22","author":"M Moccia","year":"2015","unstructured":"Moccia M, Picillo M, Erro R, Vitale C, Longo K, Amboni M, et al. Presence and progression of non-motor symptoms in relation to uric acid in de novo Parkinson\u2019s disease. Eur J Neurol. 2015;22(1):93\u20138.","journal-title":"Eur J Neurol"},{"key":"1050_CR44","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.parkreldis.2018.05.010","volume":"55","author":"X Huang","year":"2018","unstructured":"Huang X, Ng SY, Chia NS, Acharyya S, Setiawan F, Lu ZH, et al. Serum uric acid level and its association with motor subtypes and non-motor symptoms in early Parkinson\u2019s disease: PALS study. Parkinsonism Relat Disord. 2018;55:50\u20134.","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"1050_CR45","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/ene.14070","volume":"27","author":"YS Oh","year":"2020","unstructured":"Oh YS, Kim JS, Yoo SW, Hwang EJ, Lyoo CH, Lee KS. Gender difference in the effect of uric acid on striatal dopamine in early Parkinson\u2019s disease. Eur J Neurol. 2020;27(2):258\u201364.","journal-title":"Eur J Neurol"},{"key":"1050_CR46","doi-asserted-by":"crossref","unstructured":"Parkinson Study Group S-PDI, Schwarzschild MA, Ascherio A, Beal MF, Cudkowicz ME, Curhan GC, et al. Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial. JAMA Neurol. 2014;71(2):141\u201350.","DOI":"10.1001\/jamaneurol.2013.5528"},{"issue":"14","key":"1050_CR47","doi-asserted-by":"publisher","first-page":"e1328","DOI":"10.1212\/WNL.0000000000008194","volume":"93","author":"MA Schwarzschild","year":"2019","unstructured":"Schwarzschild MA, Macklin EA, Bakshi R, Battacharyya S, Logan R, Espay AJ, et al. Sex differences by design and outcome in the Safety of Urate Elevation in PD (SURE-PD) trial. Neurology. 2019;93(14):e1328\u201338.","journal-title":"Neurology"},{"issue":"6","key":"1050_CR48","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1002\/ana.24281","volume":"76","author":"KC Simon","year":"2014","unstructured":"Simon KC, Eberly S, Gao X, Oakes D, Tanner CM, Shoulson I, et al. Mendelian randomization of serum urate and Parkinson disease progression. Ann Neurol. 2014;76(6):862\u20138.","journal-title":"Ann Neurol"},{"key":"1050_CR49","doi-asserted-by":"crossref","unstructured":"Kia DA, Noyce AJ, White J, Speed D, Nicolas A, collaborators I, et al. Mendelian randomization study shows no causal relationship between circulating urate levels and Parkinson\u2019s disease. Ann Neurol. 2018;84(2):191\u20139.","DOI":"10.1002\/ana.25294"},{"issue":"2","key":"1050_CR50","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/ana.25292","volume":"84","author":"CJ Kobylecki","year":"2018","unstructured":"Kobylecki CJ, Nordestgaard BG, Afzal S. Plasma urate and risk of Parkinson\u2019s disease: a Mendelian randomization study. Ann Neurol. 2018;84(2):178\u201390.","journal-title":"Ann Neurol"},{"key":"1050_CR51","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.parkreldis.2018.03.026","volume":"52","author":"M Cortese","year":"2018","unstructured":"Cortese M, Riise T, Engeland A, Ascherio A, Bjornevik K. Urate and the risk of Parkinson\u2019s disease in men and women. Parkinsonism Relat Disord. 2018;52:76\u201382.","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"1050_CR52","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12031-016-0848-y","volume":"61","author":"L Du","year":"2017","unstructured":"Du L, Ma J, Zhang X. Higher serum uric acid may contribute to cerebral infarction in patients with type 2 diabetes mellitus: a meta-analysis. J Mol Neurosci. 2017;61(1):25\u201331.","journal-title":"J Mol Neurosci"},{"key":"1050_CR53","doi-asserted-by":"crossref","unstructured":"Zhong C, Zhong X, Xu T, Xu T, Zhang Y. Sex-specific relationship between serum uric acid and risk of stroke: a dose-response meta-analysis of prospective studies. J Am Heart Assoc. 2017;6(4).","DOI":"10.1161\/JAHA.116.005042"},{"key":"1050_CR54","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.atherosclerosis.2018.07.002","volume":"275","author":"Z Zhou","year":"2018","unstructured":"Zhou Z, Liang Y, Lin J, Zhang X, Qu H, Xu J, et al. Serum uric acid concentrations and risk of intracerebral hemorrhage: a systematic review and meta-analysis. Atherosclerosis. 2018;275:352\u20138.","journal-title":"Atherosclerosis"},{"issue":"1","key":"1050_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2014.02.001","volume":"234","author":"J Huang","year":"2014","unstructured":"Huang J, Hu D, Wang Y, Zhang D, Qu Y. Dose-response relationship of serum uric acid levels with risk of stroke mortality. Atherosclerosis. 2014;234(1):1\u20133.","journal-title":"Atherosclerosis"},{"issue":"4","key":"1050_CR56","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jacc.2015.10.086","volume":"67","author":"T Keenan","year":"2016","unstructured":"Keenan T, Zhao W, Rasheed A, Ho WK, Malik R, Felix JF, et al. Causal assessment of serum urate levels in cardiometabolic diseases through a Mendelian randomization study. J Am Coll Cardiol. 2016;67(4):407\u201316.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1050_CR57","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/NRL.0000000000000234","volume":"24","author":"Z Lei","year":"2019","unstructured":"Lei Z, Cai J, Hong H, Wang Y. Serum uric acid level and outcome of patients with ischemic stroke: a systematic review and meta-analysis. Neurologist. 2019;24(4):121\u201331.","journal-title":"Neurologist"},{"issue":"3","key":"1050_CR58","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1007\/s12035-015-9134-1","volume":"53","author":"Z Wang","year":"2016","unstructured":"Wang Z, Lin Y, Liu Y, Chen Y, Wang B, Li C, et al. Serum uric acid levels and outcomes after acute ischemic stroke. Mol Neurobiol. 2016;53(3):1753\u20139.","journal-title":"Mol Neurobiol"},{"issue":"5","key":"1050_CR59","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S1474-4422(14)70054-7","volume":"13","author":"A Chamorro","year":"2014","unstructured":"Chamorro A, Amaro S, Castellanos M, Segura T, Arenillas J, Marti-Fabregas J, et al. Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 2b\/3 trial. Lancet Neurol. 2014;13(5):453\u201360.","journal-title":"Lancet Neurol"},{"issue":"8","key":"1050_CR60","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1161\/STROKEAHA.115.009960","volume":"46","author":"L Llull","year":"2015","unstructured":"Llull L, Laredo C, Renu A, Perez B, Vila E, Obach V, et al. Uric acid therapy improves clinical outcome in women with acute ischemic stroke. Stroke. 2015;46(8):2162\u20137.","journal-title":"Stroke"},{"issue":"11","key":"1050_CR61","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1161\/STROKEAHA.116.014672","volume":"47","author":"S Amaro","year":"2016","unstructured":"Amaro S, Laredo C, Renu A, Llull L, Rudilosso S, Obach V, et al. Uric acid therapy prevents early ischemic stroke progression: a tertiary analysis of the URICO-ICTUS trial (efficacy study of combined treatment with uric acid and r-tPA in acute ischemic stroke). Stroke. 2016;47(11):2874\u20136.","journal-title":"Stroke"},{"issue":"4","key":"1050_CR62","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1177\/1747493016684354","volume":"12","author":"A Chamorro","year":"2017","unstructured":"Chamorro A, Amaro S, Castellanos M, Gomis M, Urra X, Blasco J, et al. Uric acid therapy improves the outcomes of stroke patients treated with intravenous tissue plasminogen activator and mechanical thrombectomy. Int J Stroke. 2017;12(4):377\u201382.","journal-title":"Int J Stroke"},{"issue":"3","key":"1050_CR63","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s12031-018-1096-0","volume":"65","author":"F Crosta","year":"2018","unstructured":"Crosta F, Occhiuzzi U, Passalacqua G, Occhiuzzi E, Cimini A, Grassi D, et al. Association between the serum uric acid levels and lacunar infarcts in the elderly. J Mol Neurosci. 2018;65(3):385\u201390.","journal-title":"J Mol Neurosci"},{"issue":"3","key":"1050_CR64","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/jon.12308","volume":"26","author":"SW Han","year":"2016","unstructured":"Han SW, Song TJ, Bushnell CD, Lee SS, Kim SH, Lee JH, et al. Serum uric acid is associated with cerebral white matter hyperintensities in patients with acute lacunar infarction. J Neuroimaging. 2016;26(3):351\u20134.","journal-title":"J Neuroimaging"},{"issue":"10","key":"1050_CR65","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1111\/ene.13378","volume":"24","author":"SM Jeong","year":"2017","unstructured":"Jeong SM, Yoo TG, Nam YS, Kim SH, Lee JE, Kim S, et al. Sex-dependent effects of uric acid on cerebral microbleed: a cross-sectional study in the general population. Eur J Neurol. 2017;24(10):1300\u20136.","journal-title":"Eur J Neurol"},{"key":"1050_CR66","doi-asserted-by":"crossref","unstructured":"Ryu WS, Kim CK, Kim BJ, Lee SH. Serum uric acid levels and cerebral microbleeds in patients with acute ischemic stroke. PLoS One. 2013;8(1):e55210.","DOI":"10.1371\/journal.pone.0055210"},{"issue":"14","key":"1050_CR67","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1212\/01.wnl.0000277468.10236.f1","volume":"69","author":"DJ Schretlen","year":"2007","unstructured":"Schretlen DJ, Inscore AB, Vannorsdall TD, Kraut M, Pearlson GD, Gordon B, et al. Serum uric acid and brain ischemia in normal elderly adults. Neurology. 2007;69(14):1418\u201323.","journal-title":"Neurology"},{"issue":"12","key":"1050_CR68","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.3109\/00207454.2015.1128903","volume":"126","author":"MJ Sun","year":"2016","unstructured":"Sun MJ, Li BH, Long CY, Wang YQ, Zhou Y, Liu Y, et al. Association between serum uric acid levels and cerebral white matter lesions in Chinese individuals. Int J Neurosci. 2016;126(12):1103\u201311.","journal-title":"Int J Neurosci"},{"issue":"10004","key":"1050_CR69","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/S0140-6736(15)00463-8","volume":"386","author":"JT O'Brien","year":"2015","unstructured":"O\u2019Brien JT, Thomas A. Vascular dementia. Lancet. 2015;386(10004):1698\u2013706.","journal-title":"Lancet"},{"issue":"1","key":"1050_CR70","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12916-017-0890-9","volume":"15","author":"T Bardin","year":"2017","unstructured":"Bardin T, Richette P. Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options. BMC Med. 2017;15(1):123.","journal-title":"BMC Med"},{"key":"1050_CR71","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s13075-015-0642-1","volume":"17","author":"JY Hong","year":"2015","unstructured":"Hong JY, Lan TY, Tang GJ, Tang CH, Chen TJ, Lin HY. Gout and the risk of dementia: a nationwide population-based cohort study. Arthritis Res Ther. 2015;17:139.","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"1050_CR72","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1136\/annrheumdis-2014-206917","volume":"75","author":"N Lu","year":"2016","unstructured":"Lu N, Dubreuil M, Zhang Y, Neogi T, Rai SK, Ascherio A, et al. Gout and the risk of Alzheimer\u2019s disease: a population-based. BMI-matched cohort study Ann Rheum Dis. 2016;75(3):547\u201351.","journal-title":"BMI-matched cohort study Ann Rheum Dis"},{"issue":"11","key":"1050_CR73","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1002\/art.41008","volume":"71","author":"AB Vargas-Santos","year":"2019","unstructured":"Vargas-Santos AB, Neogi T, da Rocha C-P, Kapetanovic MC, Turkiewicz A. Cause-specific mortality in gout: novel findings of elevated risk of non-cardiovascular-related deaths. Arthritis Rheumatol. 2019;71(11):1935\u201342.","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"1050_CR74","first-page":"1243","volume":"77","author":"JA Singh","year":"2018","unstructured":"Singh JA, Cleveland JD. Use of urate-lowering therapies is not associated with an increase in the risk of incident dementia in older adults. Ann Rheum Dis. 2018;77(8):1243\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1050_CR75","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/1756-185X.13548","volume":"22","author":"YH Lee","year":"2019","unstructured":"Lee YH. Gout and the risk of Alzheimer\u2019s disease: a Mendelian randomization study. Int J Rheum Dis. 2019;22(6):1046\u201351.","journal-title":"Int J Rheum Dis"},{"issue":"10","key":"1050_CR76","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.parkreldis.2015.08.030","volume":"21","author":"P Ungprasert","year":"2015","unstructured":"Ungprasert P, Srivali N, Thongprayoon C. Gout is not associated with a lower risk of Parkinson\u2019s disease: a systematic review and meta-analysis. Parkinsonism Relat Disord. 2015;21(10):1238\u201342.","journal-title":"Parkinsonism Relat Disord"},{"key":"1050_CR77","doi-asserted-by":"crossref","unstructured":"Singh JA, Cleveland JD. Gout and the risk of Parkinson\u2019s disease in older adults: a study of U.S. Medicare data. BMC Neurol. 2019;19(1):4.","DOI":"10.1186\/s12883-018-1234-x"},{"issue":"1","key":"1050_CR78","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1186\/s12883-020-01916-9","volume":"20","author":"LY Hu","year":"2020","unstructured":"Hu LY, Yang AC, Lee SC, You ZH, Tsai SJ, Hu CK, et al. Risk of Parkinson\u2019s disease following gout: a population-based retrospective cohort study in Taiwan. BMC Neurol. 2020;20(1):338.","journal-title":"BMC Neurol"},{"issue":"12","key":"1050_CR79","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1093\/rheumatology\/ket293","volume":"52","author":"OO Seminog","year":"2013","unstructured":"Seminog OO, Goldacre MJ. Gout as a risk factor for myocardial infarction and stroke in England: evidence from record linkage studies. Rheumatology (Oxford). 2013;52(12):2251\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"1050_CR80","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1136\/annrheumdis-2014-205252","volume":"74","author":"LE Clarson","year":"2015","unstructured":"Clarson LE, Hider SL, Belcher J, Heneghan C, Roddy E, Mallen CD. Increased risk of vascular disease associated with gout: a retrospective, matched cohort study in the UK clinical practice research datalink. Ann Rheum Dis. 2015;74(4):642\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1050_CR81","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s13075-017-1427-5","volume":"19","author":"JA Singh","year":"2017","unstructured":"Singh JA, Ramachandaran R, Yu S, Yang S, Xie F, Yun H, et al. Is gout a risk equivalent to diabetes for stroke and myocardial infarction? A retrospective claims database study. Arthritis Res Ther. 2017;19(1):228.","journal-title":"Arthritis Res Ther"},{"key":"1050_CR82","doi-asserted-by":"crossref","unstructured":"Yen FS, Hsu CC, Li HL, Wei JC, Hwu CM. Urate-lowering therapy may mitigate the risks of hospitalized stroke and mortality in patients with gout. PLoS One. 2020;15(6):e0234909.","DOI":"10.1371\/journal.pone.0234909"},{"issue":"12","key":"1050_CR83","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1080\/15257770.2011.611483","volume":"30","author":"I Sebesta","year":"2011","unstructured":"Sebesta I, Stiburkova B, Bartl J, Ichida K, Hosoyamada M, Taylor J, et al. Diagnostic tests for primary renal hypouricemia. Nucleosides Nucleotides Nucleic Acids. 2011;30(12):1112\u20136.","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"11","key":"1050_CR84","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1007\/s00431-013-1986-7","volume":"172","author":"S Fujinaga","year":"2013","unstructured":"Fujinaga S, Ito A, Nakagawa M, Watanabe T, Ohtomo Y, Shimizu T. Posterior reversible encephalopathy syndrome with exercise-induced acute kidney injury in renal hypouricemia type 1. Eur J Pediatr. 2013;172(11):1557\u201360.","journal-title":"Eur J Pediatr"},{"issue":"3","key":"1050_CR85","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s40620-014-0073-0","volume":"28","author":"LJ Mou","year":"2015","unstructured":"Mou LJ, Jiang LP, Hu Y. A novel homozygous GLUT9 mutation cause recurrent exercise-induced acute renal failure and posterior reversible encephalopathy syndrome. J Nephrol. 2015;28(3):387\u201392.","journal-title":"J Nephrol"},{"issue":"6","key":"1050_CR86","doi-asserted-by":"publisher","first-page":"e1621","DOI":"10.1542\/peds.2010-2592","volume":"127","author":"Y Shima","year":"2011","unstructured":"Shima Y, Nozu K, Nozu Y, Togawa H, Kaito H, Matsuo M, et al. Recurrent EIARF and PRES with severe renal hypouricemia by compound heterozygous SLC2A9 mutation. Pediatrics. 2011;127(6):e1621\u20135.","journal-title":"Pediatrics"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-021-01050-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11926-021-01050-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-021-01050-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T20:56:18Z","timestamp":1699995378000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11926-021-01050-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":86,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1050"],"URL":"https:\/\/doi.org\/10.1007\/s11926-021-01050-6","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"19 October 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"82"}}